scholarly article | Q13442814 |
P356 | DOI | 10.1371/JOURNAL.PPAT.1008795 |
P698 | PubMed publication ID | 32716975 |
P50 | author | Sita Awasthi | Q88784691 |
Gary H Cohen | Q88784699 | ||
Harvey M. Friedman | Q89912954 | ||
Lauren M. Hook | Q42230866 | ||
Norbert Pardi | Q88256458 | ||
Drew Weissman | Q88608402 | ||
P2093 | author name string | Kevin P Egan | |
Alexis Naughton | |||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P921 | main subject | Herpes simplex virus type 1 | Q655331 |
genital herpes | Q7476596 | ||
RNA vaccine | Q85795487 | ||
Human herpesvirus 2 | Q18965147 | ||
P304 | page(s) | e1008795 | |
P577 | publication date | 2020-07-27 | |
P1433 | published in | PLOS Pathogens | Q283209 |
P1476 | title | An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection | |
P478 | volume | 16 |